Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA-Dependent Tumor Immune Microenvironment.

Cancer medicine·2026

Same author

Conserved anterior/posterior tissue asymmetry encodes proximal/distal positional information during axolotl limb regeneration.

Cell reports·2026

Same author

SRW-YOLOv8n: a high-precision method for main-stem detection and clamping-point positioning of plug pepper seedlings.

Frontiers in plant science·2026

Same author

Electrochemical deoxygenative sulfenylation of aminopyrazoles with sodium sulfinates.

Chemical communications (Cambridge, England)·2026

Same author

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

Blood advances·2026

Same author

Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.

Transplantation and cellular therapy·2026

Search research articles

Related Experiment Video

Updated: Aug 5, 2025

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

A Comprehensive and Integrative Approach to MeCP2 Disease Transcriptomics.

Alexander J Trostle^1,2, Lucian Li^1,2, Seon-Young Kim^1,3

¹Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX 77030, USA.

International Journal of Molecular Sciences

|March 29, 2023

Summary

Mutations in methyl-CpG-binding protein 2 (MeCP2) cause neurological disease. Analyzing public transcriptomic data revealed a core set of consistently disrupted genes, offering a clearer molecular picture of MeCP2 dysfunction.

Keywords:

MeCP2 MeCP2 duplication syndrome RNA-seq Rett syndrome data portal differential expression analysis meta-analysis mouse models

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Related Experiment Videos

Last Updated: Aug 5, 2025

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Area of Science:

Neuroscience
Genomics
Bioinformatics

Background:

Mutations in the methyl-CpG-binding protein 2 (MeCP2) gene are linked to severe neurological disorders.
Previous transcriptomic studies on MeCP2 dysfunction have produced inconsistent results regarding differentially expressed genes.
A comprehensive understanding of MeCP2's molecular function and the impact of its mutations is lacking.

Purpose of the Study:

To develop and apply a robust methodology for analyzing aggregated public transcriptomic data to identify consistently dysregulated genes in MeCP2-related disorders.
To create an interactive web portal for accessing and exploring mouse transcriptomic data related to MeCP2.
To establish a reliable molecular signature of MeCP2 dysregulation.

Main Methods:

Acquisition of raw transcriptomic data from public repositories (GEO, ENA).
Homogeneous data processing including quality control, alignment to reference genomes, and differential gene expression analysis.
Development of a web portal for interactive data exploration and visualization.

Main Results:

Identification of a common core set of perturbed genes across multiple transcriptomic studies, overcoming individual study limitations.
Discovery of functionally distinct, consistently upregulated and downregulated gene subsets within the core set.
Observed enrichment of the mouse MeCP2 core gene set in other species' models and overlap with autism spectrum disorder (ASD) models.

Conclusions:

Large-scale integration of transcriptomic data provides an unbiased and accurate molecular signature of MeCP2 dysregulation.
The identified core gene set offers a more reliable basis for understanding MeCP2's molecular role in neurological disease.
This data-driven framework facilitates future research into MeCP2-associated disorders and related conditions like ASD.